Nav: Home

Hidden signs in cancer tissue

August 08, 2018

A research team led by Gunnar Raetsch, Professor of Biomedical Informatics at ETH Zurich, has evaluated the largest set of genetic data in cancer medicine: The Cancer Genome Atlas in the United States (see box). The Atlas compiles genetic information on tumor cells from several thousand cancer patients and 33 types of cancer at DNA and RNA level. Through their analysis, the ETH scientists have discovered new cancer-specific molecular changes that could potentially inform the development of cancer treatments.

Many previous genetic analyses of cancer cells have concentrated on their DNA - the "basic" version of the genetic information, so to speak. Such studies examined genes to see if they contained tumor-specific mutations. In addition, it was studied if the genes were especially active or inactive depending on the tumor.

Now the ETH researchers have gone a step further and taken a closer look at the RNA molecules, which are responsible for transcribing the cell's DNA. But before these molecules can serve as a blueprint for the biosynthesis of proteins, they undergo a series of transformative cellular processes: in a process called splicing, specialised enzymes cut out entire sections from the RNA molecule and join the sequences on either side together. An RNA molecule can be spliced in a range of different ways, which experts refer to as "alternative splicing". In other words, as a copy of a gene an RNA molecule can deliver the blueprint for various protein forms, the groundwork for which is laid during splicing.

Alternative splicing happens frequently

In their analysis for tumor-specific alternative splicing, Rätsch and his colleagues looked at an unprecedented volume of genetic cancer data, examining sequences in RNA molecules from 8,700 cancer patients. They found several ten thousand previously undescribed variants of alternative splicing that crop up over and over in many cancer patients.

The researchers were also able to show that in the majority of the cancer types tested, alternative splicing occurred much more frequently in tumor tissues than in healthy tissues. It is especially pronounced in pulmonary adenocarcinomas, where alternative splicing occurs 30 percent more frequently than in healthy samples.

Thanks to this study, the researchers gained new insights into which molecular factors cause the high rate of alternative splicing in cancer cells. Some genetic mutations that encourage alternative splicing are already known, but now the team was able to identify another four genes involved.

New docking sites for immunotherapy

"Cancer leads to molecular and functional changes in cells. You could say that in cancer cells, there's lots of sand in the gears," says André Kahles, a postdoc in Rätsch's group and one of the study's two lead authors. "At the molecular level the changes come not only in the form of individual DNA mutations, which we've known about for a long time, but also to a great extent in the form of different kinds of RNA splicing, as we were able to show in our comprehensive analysis."

Not all of the newly discovered molecular changes in RNA necessarily also cause functional changes in cancer cells, the researchers say. Still, the molecular differences can inform novel therapy approaches - for instance, cells that feature splicing patterns typical for cancer could be treated with immunotherapy.

In targeted cancer immunotherapy, the body's own immune system is trained to recognise typical molecular cancer markers so it can attack and kill cancer tissue. Healthy body tissue is left alone.

At present only a minority of cancer patients can be treated with this method, since tumor-specific markers suitable for use in immunotherapy were present in only some 30 percent of cases. The newly discovered variations of alternative splicing lead to changes in proteins that in turn can also serve as tumor-specific markers: up to 75 percent of cases were found to exhibit these new markers that could potentially be used for developing specific medications.

In-depth analysis of larger datasets

Simply obtaining information on the frequency of alternative splicing is in itself highly valuable. Specifically, the scientists theorise that tumor tissue with many splicing operations is particularly vulnerable to another type of immunotherapy, namely non-targeted immunotherapy. They wish to explore this hypothesis as part of the ETH Domain's Personalized Health and Related Technologies (PHRT) research programme.

For the study described here, the researchers analysed several hundred terabytes of raw data. "To analyse such huge volumes of data, we needed an enormous amount of computer time and fast storage systems. Without a supercomputer, the study would not have been possible," ETH Professor Rätsch says. He and his colleagues came to ETH Zurich two years ago from Memorial Sloan Kettering Cancer Center in New York, where they had started the study. Once in Switzerland, they joined forces with ETH's IT Services to set up the Leonhard Med computer system, which let them securely process gigantic sets of genomic and other medical data.
-end-
The Cancer Genome Atlas

The Cancer Genome Atlas (TCGA) is a large-scale project of two U.S. national health institutes. Over the past 13 years, TCGA has compiled and analysed genetic data from tumor tissue and normal tissue from several thousand American patients. The project came to a close at the end of last year as planned; however, the collaborating institutes announced that there will be follow-up projects building on TCGA and the insights it produced. By collecting and analysing the numerous molecular changes that drive various forms of cancer, the project aimed to lay the foundation for their early detection, prevention and treatment.

References

Kahles A, Lehmann KV, Toussaint NC, Hüser M, Stark S, Sachsenberg T, Stegle O, Kohlbacher O, Sander C, The Cancer Genome Atlas Research Network, Rätsch G: Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients. Cancer Cell 2018, doi: 10.1016/j.ccell.2018.07.001

ETH Zurich

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Teaching For Better Humans
More than test scores or good grades — what do kids need to prepare them for the future? This hour, guest host Manoush Zomorodi and TED speakers explore how to help children grow into better humans, in and out of the classroom. Guests include educators Olympia Della Flora and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#535 Superior
Apologies for the delay getting this week's episode out! A technical glitch slowed us down, but all is once again well. This week, we look at the often troubling intertwining of science and race: its long history, its ability to persist even during periods of disrepute, and the current forms it takes as it resurfaces, leveraging the internet and nationalism to buoy itself. We speak with Angela Saini, independent journalist and author of the new book "Superior: The Return of Race Science", about where race science went and how it's coming back.